Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
criteria which requires that they have lived in the EEA, Switzerland, the UK or Gibraltar for at least the three years preceding the start date of the research degree programme. Applicants who already hold a
-
preceding the start date of the research degree programme. Applicants who already hold a doctoral degree or who have been registered on a programme of research leading to the award of a doctoral degree on a
-
access and the necessary training to the Animotive VR SaaS product. This will enable the PhD candidate to have the skills and knowledge base to roll out a programme of participatory research engagement
-
the start date of the research degree programme. Applicants who already hold a doctoral degree or who have been registered on a programme of research leading to the award of a doctoral degree on a full-time
-
for at least the three years preceding the start date of the research degree programme. Applicants who already hold a doctoral degree or who have been registered on a programme of research leading
-
that they have lived in the EEA, Switzerland, the UK or Gibraltar for at least the three years preceding the start date of the research degree programme. Applicants who already hold a doctoral degree or who have
-
criteria which requires that they have lived in the EEA, Switzerland, the UK or Gibraltar for at least the three years preceding the start date of the research degree programme. Applicants who already hold a
-
Summary Applicants are invited to undertake a 3 year PhD program in partnership with a global leader in blood- and cell-based therapies (Terumo Blood and Cell Technologies Ltd). This opportunity
-
for at least the three years preceding the start date of the research degree programme. Applicants who already hold a doctoral degree or who have been registered on a programme of research leading
-
for metabolic disorders such as diabetes and obesity. However, their efficacy and safety in humans remains unexplored. This PhD programme will seek to take the first critical step towards clinical translation